基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 EGF816 那扎替尼(EGF816)
  • aladdin 阿拉丁 N413844 那扎替尼(EGF816) 1508250-71-2 97%

aladdin 阿拉丁 N413844 那扎替尼(EGF816) 1508250-71-2 97%

Nazartinib (EGF816)
1508250-71-2
674.90 5mg 起订
2699.90 25mg 起订
5999.90 100mg 起订
上海 更新日期:2025-05-16

上海阿拉丁生化科技股份有限公司

VIP3年
联系人:阿拉丁客服
电话:400-6206333拨打
手机:13167063860 拨打
邮箱:anhua.mao@aladdin-e.com

产品详情:

中文名称:
那扎替尼(EGF816)
英文名称:
Nazartinib (EGF816)
CAS号:
1508250-71-2
品牌:
阿拉丁
产地:
上海
保存条件:
-20°C储存
纯度规格:
Moligand™, ≥97%
产品类别:
小分子和化合物库 配体家族
分子式:
C26H31ClN6O2
分子量:
495.02
运输条件:
超低温运输
产品规格:
25mg、5mg、100mg
货号:
N413844
是否进口:

中文名:那扎替尼(EGF816)

英文名:Nazartinib (EGF816)

纯度:Moligand™,≥97%

货号:N413844

Cas号:1508250-71-2

存储温度:-20°C储存

运输条件:超低温运输

产品介绍:

Information

Nazartinib (EGF816, NVS-816) is a covalent, irreversible, mutant-selectiveEGFRinhibitor that has nanomolar inhibitory potency against activating mt (L858R, ex19del) and T790M mt, with up to 60-fold selectivity over wild type (wt) EGFR in vitro.


Targets

mutant EGFR 0.031 μM(Ki)


In vitro

EGF816 is a novel, covalent, mutant-selective EGFR inhibitor with nearly equipotent activity on both oncogenic (L858R and ex19del) and T790M-resistant mutations and good selectivity over WT EGFR. EGF816 potently inhibits the most common EGFR mutations L858R, Ex19del, and T790M in vitro. The cellular activity of EGF816 on EGFR mutants are assessed using three well-characterized cell lines, H3255, HCC827, and H1975, which harbor the L858R, Ex19del, and L858R/T790M mutations, respectively. After incubation with cells for 3 hours, EGF816 shows potent inhibition of pEGFR levels in H3255, HCC827, and H1975 with EC50 values of 5, 1, and 3 nmol/L, respectively. Cellular-based assays shows that EGF816 is selective toward mutant over WT EGFR.


In vivo

EGF816 is well tolerated and possesses favorable physicochemical properties and good oral bioavailability in mice. It shows moderate volume of distribution and low to moderate clearance in rodents (30% and 35% of rat and mouse liver blood flow, respectively). In the dog, EGF816 shows high clearance and high volume of distribution. EGF816 also demonstrates antitumor activity in an exon 20 insertion mutant model. At levels above efficacious doses, EGF816 treatment leads to minimal inhibition of WT EGFR and is well tolerated. In single-dose studies, EGF816 provides sustained inhibition of EGFR phosphorylation, consistent with its ability for irreversible binding. EGF816 has a longer half-life in human than mouse and is currently being evaluated in phase I/II clinical trials in patients harboring EGFR mutations, including T790M.


Cell Research(from reference)

Cell lines:H1975, H3255, HCC827, A431, and HaCaT cells 

Incubation Time:3 h 


查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/N413844.html


N-(7-CHLORO-1-((3R)-1-((2E)-4-(DIMETHYLAMINO) BUT-2-ENOYL)AZEPAN-3-YL)-1HBENZIMIDAZOLOL-2-YL)-2-METHYLPYRIDINE-4-CARBOXAMIDE ; D11430 ; s7824 ; A14416

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (17年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

那扎替尼(EGF816)相关厂家报价 更多

  • nazartinib
  • nazartinib
  • 上海芮晖化工科技有限公司 VIP
  • 2025-12-15
  • 询价
  • EGF816
  • EGF816
  • Shenzhen Tuoda Pharmatech Co., Ltd
  • 2017-06-06
  • 询价
内容声明
拨打电话 立即询价